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EDITORIAL 
Annual Meeting Theme for 1992: Developmental 
Neurobiology and Clinical Course 
Four salient features of pathophysiology receive inadequate attention in biological psy- 
chiatry. First, most psychiatric disorders have relatively characteristic ages of onset. 
Second, most have a lifetime course. Third, the clinical phenomenology associated with 
a given diagnosis tends to change as the person ages. Fourth, gender and reproductive 
milestones strongly influence clinical onset, features and course. These observations 
suggest that neurobiological changes in the brain associated with aging and development 
are profoundly important in understanding pathophysiology and clinical presentation of 
psychiatric disorders. What are these neurobiological changes? When and where in the 
brain do they occur? Can they be predicted? Recognized clinically? Identified by laboratory 
tests? Altered by treatment? Sadly, many of these questions cannot be answered, since 
we know too little about developmental neurobiology and clinical course. ~ i s  void exists 
despite the fact that longitudinal course may be the most important aspect of clinical 
psychiatry. 
In a small attempt to fill this void and stimulate future investigation, the 1992 Scientific 
Meeting of the Society of Biological Psychiatry (in Washington, DC, April 29-May 3) 
wil' highlight the theme "Developmental Neurobiology and Clinical Course." 
As background, let us review briefly the evidence supporting the above observations. 
Some entities such as Tourette's disorder, attention deficit disorder, and autism usually 
appear during childhood. Others---schizophrenia and panic disorder are examples---have 
onsets predominantly during childhood, adolescence and young adulthood. Some can 
present at any age, but with incidence progressively increasing as years go by; major 
depression, once erroneously believed to be a disease of middle age is an example. Still 
other syndromes, such as Alzheimer's dementia, seemingly occur only in the aging b ~ ,  
almost never appearing at a young age (although the brains of patients with Down's 
Syndrome have neuropathological features in common with Alzheimer's). For c e ~  
pathophysioiogies, there clearly are high risk periods followed by a lessening of risk if 
the hazardous period is safely passed. For other disorders there is a progressive increase 
of risk with each passing year. Expanding our knowledge base about the mechanisms 
underlying these risk milestones may tell us a great deal about the etiology of many 
disorders. 
Regarding longitudinal course, most psychiatric disorders, once developed, do not go 
away permanently. Some are episodic and recurrent, others chronic and stable, still others 
chronic and deteriorating; but sadly, most persist over the life cycle. Lifetime course is 
so characteristic for some disorders that it may be a more powerful predictor of diagnosis 
than are clinical features. For example, if a clinician were informed that a patient had 
initial onset of clinical symptoms after childbirth, good short-term resolution of symptoms, 
five or six similar episodes over the next two decades, with episodes getting closer together 
as the years passed, even if that clinician were never aware of a single clinical symptom, 
he or she would have an extremely high likelihood of accurately diag~3osing an affective 
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disorder. What neurobiological network induces this episodic, recurrent course in the 
brain of some depressives? How many patients have it? Are aging and the number of 
depressive episodes interactive in its production? Is the pattern consistent in family 
cohorts? D ~ s  its pre.,;ence have predictive importance in planning maintenance treatment? 
This litany of important but largely unanswered questions could be repeated for most 
psychiatric disorders included in DSM-III-R. 
The ~.hird observation addresses clinical phenomenology across the life cycle. Con- 
siderable data suggest that clinical features for a given diagnosis are not the same at all 
ages. An 80 year old with depression generally presents with a different constellation 
than an eight year old, with the elderly person being more likely to manifest agitation, 
hyposomnia, hypophagia and psychosis. Depression is not necessarily identical at all 
ages. Neither are most other diagnoses. Why? 
The final observation--that gender and reproductive milestones profoundly influence 
clinical onset, features and course--also is amply supported by clinical experience. Some 
disorders, such as anorexia nervosa, bulimia, and borderline personality disorder tend to 
be almost exclusively associated with women; others, such as Tourette's, alcoholism and 
sociopathy are preponderant in men. Puberty induces a major shift in the sex ratio of 
depressed children, from a male preponderance before puberty to a female preponderance 
after puberty. Certain pathophysiologies may appear or be accentuated only at certain 
times in the reproductive cycle. Again, for each of these observations, why? What are 
the underlying mechanisms? 
Longitudinal patterns are important. They are relevant to diagnosis and prognosis. 
They have made the development of laboratory tests more difficult, since "normal" results 
often change with aging. Perhaps most importantly, different longitudinal patterns prob- 
ably have major treatment implications. Emerging new data, especially for mood dis- 
orders, provide powerful support for the long-held belief that for many patients, main- 
tenance psychopharmacological treatment should receive more attention than short-term 
interventions. Rather than being preoccupied with the question of when medications can 
be discontinued, clinicians perhaps should give more attention to the question of which 
patients require ongoing medication, often including lifetime medication. 
If developmental neurobiology across the life cycle is so relevant, why has it been 
relatively neglected since the days of Kraepelin? There are a number of identifiable 
reasons. First, psychiatry's tradition of emphasizing "inpatient" and "outpatient" delivery 
systems has impeded long-term perspectives. Second, DSM-III has unduly prioritized 
cross-sectional assessment of clinical features for diagnosis, often neglecting longitudinal 
course in the process. Third, research funding as a catalyst generally has been lacking; 
longitudinal, long-term studies are difficult, costly, and time-consuming, and funding 
priorities in our institutes have rarely taken long-term perspectives. Fourth, promotion 
and tenure policies in most universities pressure junior academicians to develop short- 
term studies capable of producing publishable results sooner rather than later. Fifth, and 
perhaps most discouragingly, since it is still gaining momentum, psychiatry's penchant 
for age-oriented subspecialization is a barrier to better understanding of longitudinal 
course. Our traditional breakdown into child, adolescent and adult subspecialties has 
interfered with optimal scientific exchange (perhaps explaining why depression was not 
even recognized in children and adolescents until several decades ago); now, infant and 
geriatric subspecialties will further fragment attempts to develop a perspective on the 
complete "ages of man." This subspecialty barrier will be difficult to overcome since 
different age-oriented subspecialists generally don't practice in the same settings, don't 
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see the same patients to compare inter-rater reliability, don't attend the same meetings, 
don't talk with subspecialists who emphasize different ages, don't always talk the same 
professional language, and don't even have the same accreditation and regulatory agencies. 
The other .barriers will be just as difficult to break down. But we must try. 
In this "Decade of the Brain," it is time for biological psychiatry to rediscover de- 
velopmental neurobiology and longitudinal course, to reacquaint ourselves with the con- 
siderable knowledge we have compiled through the years, and to formulate research 
priorities for the future. This 1992 Scientific Meeting will strive to aid these initiatives. 
We look for your assistance. I am pleased to represent the officers of the Society in 
welcoming you to Washington, D.C. from April 29-May 3, 1992. It should be an excellent 
meeting. 
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